R.G. Niederhoffer Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

R.G. Niederhoffer Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,700	Closed	-$489K	–	33
2016 Q2	$489K	Sell	5,700 -2,100	-27%	-$188K	3.1%	14
2016 Q1	$678K	Buy	+7,800	New	+$698K	4.9%	9
2015 Q4	–	Sell	-15,900	Closed	-$1.61M	–	12
2015 Q3	$1.61M	Buy	+15,900	New	+$1.91M	7.93%	4

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

R.G. Niederhoffer Capital Management's IBB Position: Q3 2016 in Review

R.G. Niederhoffer Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2016, closing a stake of 5,700 shares — an estimated $489K sold.

R.G. Niederhoffer Capital Management first reported a position in IBB in Q3 2015 and held it in 3 quarters. The position peaked at $1.61M in Q3 2015. 464 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

R.G. Niederhoffer Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2016 after selling out during the quarter.
R.G. Niederhoffer Capital Management sold 5,700 iShares Biotechnology ETF shares in Q3 2016, an estimated $489K.
R.G. Niederhoffer Capital Management first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 3 quarters.
R.G. Niederhoffer Capital Management's iShares Biotechnology ETF position peaked at $1.61M in Q3 2015.
464 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on R.G. Niederhoffer Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.